OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 10:00
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
The World Is Focusing on the Wrong Climate Scoreboard
Google Tentatively Settles States’ Play Store Antitrust Suit
SoftBank’s Arm Files for IPO That Could Be 2023’s Biggest
Big Amazon cloud services recovering after outage hits thousands of users
Quarterly Earnings Season Begins. The Consensus: A Little Growth Plus Surprises.
Celent Report Finds Personetics Is the Top Banking Solution for Small Business Banking in North America
Secure your files with a portable 1TB hard drive, on sale
Three Adani Firms Lose Endorsement of UN-Backed Climate Group